Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2012 (2012), Article ID 197438, 7 pages
http://dx.doi.org/10.1155/2012/197438
Review Article

MRI Findings in Neuroferritinopathy

Department of Neurology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan

Received 12 March 2011; Revised 10 May 2011; Accepted 23 May 2011

Academic Editor: Antonio Cerasa

Copyright © 2012 Emiko Ohta and Yoshihisa Takiyama. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. R. J. Curtis, C. Fey, C. M. Morris et al., “Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease,” Nature Genetics, vol. 28, no. 4, pp. 350–354, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. R. Vidal, B. Ghetti, M. Takao et al., “Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene,” Journal of Neuropathology and Experimental Neurology, vol. 63, no. 4, pp. 363–380, 2004. View at Google Scholar · View at Scopus
  3. M. Mancuso, G. Davidzon, R. M. Kurlan et al., “Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights,” Journal of Neuropathology and Experimental Neurology, vol. 64, no. 4, pp. 280–294, 2005. View at Google Scholar · View at Scopus
  4. P. Maciel, V. T. Cruz, M. Constante et al., “Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement,” Neurology, vol. 65, no. 4, pp. 603–605, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. E. Ohta, T. Nagasaka, K. Shindo et al., “Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene,” Neurology, vol. 70, no. 16, part 2, pp. 1493–1494, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. D. Devos, P. J. Tchofo, I. Vuillaume et al., “Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation,” Brain, vol. 132, no. 6, p. e109, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. A. Kubota, A. Hida, Y. Ichikawa et al., “A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations,” Movement Disorders, vol. 24, no. 3, pp. 441–445, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. S. Levi, A. Cozzi, and P. Arosio, “Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation,” Best Practice and Research: Clinical Haematology, vol. 18, no. 2, pp. 265–276, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. R. Vidal, L. Miravalle, X. Gao et al., “Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice,” Journal of Neuroscience, vol. 28, no. 1, pp. 60–67, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. T. A. Rouault, “Iron on the brain,” Nature Genetics, vol. 28, no. 4, pp. 299–300, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. Y. Ke and Z. M. Qian, “Iron misregulation in the brain: a primary cause of neurodegenerative disorders,” Lancet Neurology, vol. 2, no. 4, pp. 246–253, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Cozzi, E. Rovelli, G. Frizzale et al., “Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy,” Neurobiology of Disease, vol. 37, no. 1, pp. 77–85, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. P. F. Chinnery, D. E. Crompton, D. Birchall et al., “Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation,” Brain, vol. 130, no. 1, pp. 110–119, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. McNeill, D. Birchall, S. J. Hayflick et al., “T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation,” Neurology, vol. 70, no. 18, pp. 1614–1619, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. P. Mir, M. J. Edwards, A. R. J. Curtis, K. P. Bhatia, and N. P. Quinn, “Adult-onset generalized dystonia due to a mutation in the neuroferritinopathy gene,” Movement Disorders, vol. 20, no. 2, pp. 243–245, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. D. E. Crompton, P. F. Chinnery, D. Bates et al., “Spectrum of movement disorders in neuroferritinopathy,” Movement Disorders, vol. 20, no. 1, pp. 95–98, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. D. Caparros-Lefebvre, A. Destée, and H. Petit, “Late onset familial dystonia: could mitochondrial deficits induce a diffuse lesioning process of the whole basal ganglia system?” Journal of Neurology, Neurosurgery and Psychiatry, vol. 63, no. 2, pp. 196–203, 1997. View at Google Scholar · View at Scopus
  18. D. E. Crompton, P. F. Chinnery, C. Fey et al., “Neuroferritinopathy: a window on the role of iron in neurodegeneration,” Blood Cells, Molecules and Diseases, vol. 29, no. 3, pp. 522–531, 2002. View at Google Scholar · View at Scopus
  19. P. M. Harrison and P. Arosio, “The ferritins: molecular properties, iron storage function and cellular regulation,” Biochimica et Biophysica Acta, vol. 1275, no. 3, pp. 161–203, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. C. W. Olanow and G. W. Arendash, “Metals and free radicals in neurodegeneration,” Current Opinion in Neurology, vol. 7, no. 6, pp. 548–558, 1994. View at Google Scholar · View at Scopus
  21. C. M. Morris, J. M. Candy, A. E. Oakley, C. A. Bloxham, and J. A. Edwardson, “Histochemical distribution of non-haem iron in the human brain,” Acta Anatomica, vol. 144, no. 3, pp. 235–257, 1992. View at Google Scholar · View at Scopus
  22. J. Stankiewicz, S. S. Panter, M. Neema, A. Arora, C. E. Batt, and R. Bakshi, “Iron in chronic brain disorders: imaging and neurotherapeutic implications,” Neurotherapeutics, vol. 4, no. 3, pp. 371–386, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. A. Gregory, B. J. Polster, and S. J. Hayflick, “Clinical and genetic delineation of neurodegeneration with brain iron accumulation,” Journal of Medical Genetics, vol. 46, no. 2, pp. 73–80, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. P. F. Chinnery, A. R. J. Curtis, C. Fey et al., “Neuroferritinopathy in a French family with late onset dominant dystonia,” Journal of Medical Genetics, vol. 40, no. 5, p. e69, 2003. View at Google Scholar · View at Scopus
  25. F. Ory-Magne, C. Brefel-Courbon, P. Payoux et al., “Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC),” Movement Disorders, vol. 24, no. 11, pp. 1676–1683, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. E. Ohta, T. Nagasaka, K. Shindo et al., “Clinical features of neuroferritinopathy,” Clinical Neurology, vol. 49, no. 5, pp. 254–261, 2009. View at Google Scholar · View at Scopus
  27. A. J. Wills, G. V. Sawle, P. R. Guilbert, and A. R. J. Curtis, “Palatal tremor and cognitive decline in neuroferritinopathy,” Journal of Neurology Neurosurgery and Psychiatry, vol. 73, no. 1, pp. 91–92, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Burn and P. F. Chinnery, “Neuroferritinopathy,” Seminars in Pediatric Neurology, vol. 13, no. 3, pp. 176–181, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. B. Zhou, S. K. Westaway, B. Levinson, M. A. Johnson, J. Gitschier, and S. J. Hayflick, “A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome,” Nature Genetics, vol. 28, no. 4, pp. 345–349, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. J. Hayflick, M. Hartman, J. Coryell, J. Gitschier, and H. Rowley, “Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations,” American Journal of Neuroradiology, vol. 27, no. 6, pp. 1230–1233, 2006. View at Google Scholar · View at Scopus
  31. S. J. Hayflick, S. K. Westaway, B. Levinson et al., “Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome,” New England Journal of Medicine, vol. 348, no. 1, pp. 33–40, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. M. C. Sharma, N. Aggarwal, M. Bihari et al., “Hallervorden Spatz disease: MR and pathological findings of a rare case,” Neurology India, vol. 53, no. 1, pp. 102–104, 2005. View at Google Scholar · View at Scopus
  33. H. Morita, S. Ikeda, K. Yamamoto et al., “Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family,” Annals of Neurology, vol. 37, no. 5, pp. 646–656, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. J. Kóbor, A. Javaid, and M. F. Omojola, “Cerebellar hypoperfusion in infantile neuroaxonal dystrophy,” Pediatric Neurology, vol. 32, no. 2, pp. 137–139, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. C. Paisan-Ruiz, K. P. Bhatia, A. Li et al., “Characterization of PLA2G6 as a locus for dystonia-parkinsonism,” Annals of Neurology, vol. 65, no. 1, pp. 19–23, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. P. Péran, G. Hagberg, G. Luccichenti et al., “Voxel-based analysis of R2* maps in the healthy human brain,” Journal of Magnetic Resonance Imaging, vol. 26, no. 6, pp. 1413–1420, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. A. Cherubini, P. Péran, C. Caltagirone, U. Sabatini, and G. Spalletta, “Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI,” Neuroimage, vol. 48, no. 1, pp. 29–36, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus